California Department of Public Health, Environmental Health Investigations Branch, Richmond, California.
Sequoia Foundation, La Jolla, California.
Autism Res. 2019 Jun;12(6):989-998. doi: 10.1002/aur.2092. Epub 2019 Mar 18.
Vitamin D deficiency has been increasing concurrently with prevalence of autism spectrum disorders (ASD), and emerging evidence suggests vitamin D is involved in brain development. Most prior studies of ASD examined vitamin D levels in children already diagnosed, but a few examined levels during perinatal development, the more likely susceptibility period. Therefore, we examined newborn vitamin D levels in a case-control study conducted among births in 2000-2003 in southern California. Children with ASD (N = 563) or intellectual disability (ID) (N = 190) were identified from the Department of Developmental Services and compared to population controls (N = 436) identified from birth certificates. 25-hydroxyvitamin D (25(OH)D) was measured in archived newborn dried blood spots by a sensitive assay and corrected to sera equivalents. We categorized 25(OH) D levels as deficient (<50 nmol/L), insufficient (50-74 nmol/L), and sufficient (≥75 nmol/L), and also examined continuous levels, using logistic regression. The adjusted odds ratios (AOR) and 95% confidence intervals for ASD were 0.96 (0.64-1.4) for 25(OH)D deficiency (14% of newborns) and 1.2 (0.86-1.6) for insufficiency (26% of newborns). The AORs for continuous 25(OH)D (per 25 nmol/L) were 1.0 (0.91-1.09) for ASD and 1.14 (1.0-1.30) for ID. Thus, in this relatively large study of measured newborn vitamin D levels, our results do not support the hypothesis of lower 25(OH)D being associated with higher risk of ASD (or ID), although we observed suggestion of interactions with sex and race/ethnicity. 25(OH)D levels were relatively high (median 84 nmol/L in controls), so results may differ in populations with higher prevalence of low vitamin D levels. Autism Res 2019, 12: 989-998. © 2019 International Society for Autism Research, Wiley Periodicals, Inc. LAY SUMMARY: We studied whether vitamin D levels measured at birth were related to whether a child later developed autism (or low IQ). Our results did not show that children with autism, or low IQ, overall had lower vitamin D levels at birth than children without autism. Vitamin D levels were fairly high, on average, in these children born in Southern California.
维生素 D 缺乏症与自闭症谱系障碍(ASD)的患病率同时增加,新出现的证据表明维生素 D 参与大脑发育。大多数先前对 ASD 的研究都检查了已经确诊的儿童的维生素 D 水平,但也有一些研究检查了围产期的水平,这是更有可能的易感期。因此,我们在加利福尼亚州南部 2000-2003 年出生的人群中进行了一项病例对照研究,检查了新生儿的维生素 D 水平。从发育服务部确定了患有 ASD(N=563)或智力障碍(ID)(N=190)的儿童,并与从出生证明中确定的人口对照(N=436)进行了比较。通过灵敏的测定法在存档的新生儿干血斑中测量 25-羟维生素 D(25(OH)D),并校正为血清当量。我们将 25(OH)D 水平分为缺乏(<50nmol/L)、不足(50-74nmol/L)和充足(≥75nmol/L),并使用逻辑回归检查连续水平。调整后的自闭症比值比(AOR)和 95%置信区间为 25(OH)D 缺乏症(新生儿的 14%)的 0.96(0.64-1.4)和不足症(新生儿的 26%)的 1.2(0.86-1.6)。连续 25(OH)D(每 25nmol/L)的 AOR 为 ASD 为 1.0(0.91-1.09),ID 为 1.14(1.0-1.30)。因此,在这项对测量的新生儿维生素 D 水平进行的相对较大的研究中,我们的结果并不支持较低的 25(OH)D 与较高的 ASD 风险(或 ID)相关的假设,尽管我们观察到性别和种族/民族存在交互作用的迹象。25(OH)D 水平相对较高(对照组中位数为 84nmol/L),因此在维生素 D 水平普遍较低的人群中,结果可能有所不同。自闭症研究 2019, 12: 989-998。 © 2019 自闭症国际研究协会,威利期刊,公司。 概述:我们研究了出生时测量的维生素 D 水平是否与孩子以后是否患有自闭症(或智商低)有关。我们的结果表明,自闭症或智商低的儿童出生时的维生素 D 水平总体上低于没有自闭症的儿童。这些在加利福尼亚南部出生的儿童的维生素 D 水平平均相当高。